Bain Capital Public Equity Management II’s Bristol-Myers Squibb BMY Stock Holding History

Bain Capital Public Equity Management II’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,600	Closed	-$221K	–	40
2019 Q3	$221K	Buy	+4,600	New	+$216K	0.02%	50

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bain Capital Public Equity Management II's BMY Position: Q2 2021 in Review

Bain Capital Public Equity Management II sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 531,424 shares — an estimated $33.5M sold.

Bain Capital Public Equity Management II first reported a position in BMY in Q1 2021 and held it in 1 quarter. The position peaked at $33.5M in Q1 2021. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

Bain Capital Public Equity Management II reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
Bain Capital Public Equity Management II sold 531,424 Bristol-Myers Squibb shares in Q2 2021, an estimated $33.5M.
Bain Capital Public Equity Management II first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 1 quarter.
Bain Capital Public Equity Management II's Bristol-Myers Squibb position peaked at $33.5M in Q1 2021.
2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Bain Capital Public Equity Management II's 13F filing for Q2 2021, filed 16 Aug 2021.